Mrs A J, aged 25. Housewife Presented for the first time in her second pregnancy on 23 April 1974. Conception had occurred despite the presence of a 'Gravigard' copper-releasing intrauterine contraceptive device (IUCD). She gave a history of congenital heart disease for which she had had surgery on two occasions. At 11 years of age an atrial septal defect (ASD) had been repaired. This operation was unsuccessful and further surgery was performed at the age of 16 years. At that time, in addition to the ASD she was found to have both mitral and tricuspid incompetence. The ASD was closed and a tricuspid anuloplasty carried out. The mitral valve was not repaired. Postoperatively she was left with mild residual tricuspid and mitral incompetence but was asymptomatic.
Obstetric history: One previous pregnancy, in 1973. The child weighed 3500 g and was delivered by elective Caesarean section because of cephalopelvic disproportion. During the pregnancy she had been asymptomatic from a cardiac point of view, but her cardiologist advised her to avoid further pregnancy for two years. For this reason she was fitted with a 'Gravigard' intrauterine contraceptive device. Conception occurred within a few months of the device being fitted and when she attended the clinic in April 1974 her uterus was 24 weeks size. She was uncertain of the date of her last menstrual period but thought that it had been in November 1973, which agreed with the clinical estimate of uterine size. Her blood group was A, rhesus negative, and anti-D antibodies were demonstrated in albumin. Her husband's blood group was A, rhesus positive (CDe/cde).
The pregnancy continued uneventfully until 4 June 1974 when it was estimated that she was about 30 weeks pregnant. She was admitted to hospital in the second stage of premature labour and spontaneous delivery of a male infant occurred within minutes of her arrival. The baby gasped at birth but showed no other signs of life. Resuscitation was attempted but without success. The baby weighed 1.19 kg (25th centile by weight for a fetus of 30 weeks gestation). Macroscopically the baby appeared normal and his blood group was A, rhesus negative. Permission for autopsy was refused. The placenta was macroscopically and microscopically normal. There was no sign of the IUCD at the delivery of the placenta but because of her heart lesion it was decided not to explore her uterus in the puerperium. Unfortunately, six days after delivery she had a postpartum heemorrhage which demanded immediate exploration of the uterus under general anmsthesia. The IUCD was found to be lying within the lower segment of the uterus from where it was removed together with about 50 g of placental tissue. Subsequently she made an uneventful recovery.
Results pf serutm copper estimations: Cord blood from the baby and venous blood from the mother were obtained immediately after attempts to resuscitate the newborn infant were abandoned. The serum copper concentrations of these samples were estimated by atomic absorption spectroscopy and the results are given in Table 1 . The serum cweruloplasmin was assayed as paraphenylene diamine oxidase activity (Houchin 1958) and the results are shown in Table 2 . The tables also show the normal ranges of copper and 5 823 al. 1974 ceruloplasmin to be expected prior to term in maternal and fetal serum as quoted by various authors.
Comment
Hagenfeldt (1972) estimated that the average loss of copper from a copper IUCD was 45 ,ug/day. Although this amount of copper does not cause a significant increase in serum copper levels (Hagenfeldt 1972 , Daunter & Elstein 1963 it does lead to an increase in the local copper concentration in the intrauterine environment (Daunter & Elstein 1963 , Oster 1972 . Copper is, however, a toxic substance and in the event of a pregnancy occurring in the presence of such a device, consideration must be given to the possible effects of copper on the developing fetus.
Copper exists in the body in two main forms:
(1) Cwrtldoplasmini: About 93% of copper exists in this form (Schenker et al. 1972) . It is a liverproduced copper-containing enzyme which has a molecular weight of 151 000 and does not cross the placenta. A gradient therefore exists across the placenta, the maternal serum containing 4-5 times more than fetal serum.
(2) Free copper: The remaining 7% of copper exists as free copper and this is loosely bound to protein in the serum but some of it manages to diffuse across the placenta.
During pregnancy the concentration of copper in the maternal serum is higher than in the non-pregnant state, and it rises gradually towards term. In the fetus, less is known about the physiology of copper in relation to gestational age. However, high concentrations are to be found in the liver and one might expect the immature liver to be less able to produce enzymes including ceruloplasmin. It has previously been shown by Hilderbrand et al. (1974) that enzyme inducers such as barbiturates produce an increase in serum copper levels in experimental animals.
Because Mrs A J's baby was delivered at about 30 weeks, one would expect lower concentrations of free copper and cwruloplasmin for both mother and baby than would have occurred at term. There is unfortunately very little available information about normal values before term. Schenker et al. (1972) studied 48 mothers and babies between 32 and 36 weeks, and found a. mean concentration of copper in maternal serum of 250 (range 214.9-285.1) ,tg/100 ml, which does not differ greatly from that found in Mrs A J. The concentration of ceruloplasmin in her serum was within the normal range reported by Scheinberg et al. (1954) in term pregnancies. However, the serum copper and ctruloplasmin concentrations found in the baby were almost twice and four times higher respectively than the ranges reported by Ganzler et al. (1972) in babies of similar gestational age and birth weight. It seems probable that although the copper and cieruloplasmin concentrations were higher in the fetus than expected, they were not much higher than would be expected to occur by term.
Little is known about the effect of copper on human tissues. However, Jones et al. (1973) showed that the 'Gravigard' (Copper 7) device stops growth and causes cell damage when placed in a culture medium with human amniotic or fibroblast cells. Hounsell & Hawkins (1974) showed that even in copper concentrations less than those occurring in uterine secretion in the presence of copper IUCDs, cell proliferation in monolayer cultures of human cervical epithelium was inhibited. Higher concentrations of copper led to total inhibition of outgrowth. They concluded that copper can cause disruption of cell function whether by interference with DNA synthesis or the premitotic phase or both.
Despite their findings, many animal and human infants delivered from mothers having copper intrauterine devices have been apparently normal (Chang & Tatum 1973 , Tatum 1973 and it may be that the fetus is isolated from the copper. It is therefore important to know how much copper, if any, reaches the fetus in such circumstances, but in no previously reported case has the cord blood copper concentration been measured.
Whilst it is appreciated that conclusions may not be drawn from single cases, my results support the suggestion that the fetus is largely, but not completely, isolated from the intrauterine coppercontaining environment. The following papers were also read: Note: 13 patients were using the sheath or diaphragm and are not included those women who had previously taken oral contraceptives, those who had used an intrauterine device, and those who had no contraception before the laparoscopic sterilization (Table 1) . The previous oral contraception users had heavier and longer menses after the operation than did those who had used no contraception (P>O.OO1).
Conversely, those who had formerly used an intrauterine contraceptive device (IUCD) reported smaller, lighter and shorter menses after sterilization and removal of the IUCD than those who had used no contraception before sterilization (P>0.05).
Thus changes in menstruation following laparoscopic sterilization may be due to factors other than the surgery itself.
[For a full account see Chamberlain & Foulkes 1976.] 
